The goals of immunologic intervention in autoimmune disease

This publication has 13 references indexed in Scilit:

• Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum
  Arthritis & Rheumatism, 1988
• Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention
  Cell, 1988
• B cells expressing cd5 are increased in sjögren's syndrome
  Arthritis & Rheumatism, 1988
• Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein.
  The Journal of Experimental Medicine, 1988
• Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis.
  The Journal of Immunology, 1988
• The Structure, Function, and Expression of Interleukin-2 Receptors on Normal and Malignant Lymphocytes
  Science, 1986
• A rheumatoid arthritis b cell subset expresses a phenotype similar to that in chronic lymphocytic leukemia
  Arthritis & Rheumatism, 1985
• Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes.
  The Journal of Experimental Medicine, 1983
• Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies.
  The Journal of Experimental Medicine, 1983
• Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein
  Nature, 1981